Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.



411 University St, Seattle, USA

+1 -800-456-478-23


Myeloid Therapeutics to Participate at Upcoming Investor Conferences

CAMBRIDGE, Mass, October 2, 2023 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the following investor conferences:

  • Chardan’s 7th Annual Genetic Medicines Conference, taking place October 2-3, 2023, in NY
  • Oppenheimer’s Private Company Symposium, taking place October 11, 2023, in NY
  • 3rd Annual Needham Private Biotech Company Virtual 1×1 Forum, taking place October 17-18, 2023

About Myeloid Therapeutics

Myeloid Therapeutics is a clinical stage oncology company developing novel therapies for cancer. Integrating the fields of mRNA-based therapeutics, immunology, and cancer biology, the Company’s proprietary platform provides clinical solutions for patients with solid tumors.

Investor and Media Contact
Amy Conrad
Juniper Point
[email protected]